Victory Capital Management
BLCM

Victory Capital Management’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Victory Capital Management’s Portfolio BLCM Stock Details BLCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,626
Closed -$8K – 3492
2020
Q1 		$8K Buy
+1,626
New +$17.5K ﹤0.01% 3395
2019
Q4 		– Sell
-779
Closed -$8K – 3477
2019
Q3 		$8K Buy
+779
New +$10.2K ﹤0.01% 3347

Other funds holding BLCM

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management's BLCM Position: Q2 2020 in Review

Victory Capital Management sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q2 2020, closing a stake of 1,626 shares — an estimated $8K sold.

Victory Capital Management first reported a position in BLCM in Q3 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2020. 27 funds tracked by Wall St. Rank hold BLCM as of Q2 2020.

  • Victory Capital Management reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,626 Bellicum Pharmaceuticals, Inc. shares in Q2 2020, an estimated $8K.
  • Victory Capital Management first reported a position in Bellicum Pharmaceuticals, Inc. in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Bellicum Pharmaceuticals, Inc. position peaked at $8K in Q1 2020.
  • 27 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.